Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kamavit-Forte is a multi-ingredient nutraceutical developed by NutriMed Group, specifically formulated to support male sexual health and reproductive function. The product combines standardized herbal extracts including *Tribulus terrestris*, *Ginkgo biloba*, and *Schisandra chinensis*. *Tribulus terrestris*, rich in protodioscin, is intended to enhance libido and support androgenic activity. *Ginkgo biloba* extract facilitates peripheral vasodilation and improves microcirculation, which is essential for erectile function, primarily through the modulation of nitric oxide signaling and antagonism of the platelet-activating factor (PAF) receptor. *Schisandra chinensis* serves as an adaptogen, helping to improve physical endurance and reduce the impact of stress on sexual performance. Kamavit-Forte is marketed for the management of erectile dysfunction, low libido, and the improvement of spermatogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kamavit-Forte.